{
    "title": "Sanofi-Regeneron drug has positive trial results in chronic sinusitis",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2774587/Sanofi-Regeneron-drug-positive-trial-results-chronic-sinusitis.html",
    "date": "2014-09-30",
    "keywords": [
        "drug",
        "trial",
        "sinusitis",
        "congestion",
        "dupilumab",
        "gmt",
        "september",
        "sanofi",
        "phase",
        "dermatitis",
        "asthma",
        "email",
        "huetparis",
        "regeneron",
        "midstage",
        "condition",
        "tuesdayin",
        "reduction",
        "size",
        "disruption",
        "saiddupilumab",
        "advance",
        "year",
        "industry",
        "publication",
        "scrip",
        "intelligence",
        "inflammation",
        "mucosa",
        "cavity",
        "sense",
        "smell",
        "relief",
        "therapy",
        "approach",
        "il4",
        "interleukin13",
        "il13sanofi",
        "disease",
        "ii",
        "atopic",
        "evidence",
        "core",
        "inflammatory",
        "process",
        "il4il13",
        "percent",
        "analysis",
        "improvement",
        "control",
        "side",
        "site",
        "nosebleed",
        "headache",
        "dizzinesssanofi",
        "study",
        "conference",
        "trialsediting",
        "goodman"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}